v3.21.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 6,556 $ 4,620
General and administrative 3,156 3,275
Total operating expenses 9,712 7,895
Loss from operations (9,712) (7,895)
Other income:    
Interest income 10 410
Net loss (9,702) (7,485)
Other comprehensive income:    
Net unrealized loss on available-for-sale investments, net of tax (3)  
Net comprehensive loss $ (9,705) $ (7,485)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.41) $ (0.33)

Source